EmilieLohse

No growth acceleration in H1 – but some optimism after reports in the Danish SaaS sector

Markedet er nu, som FED, dataafhængigt

An eventful July before the Q2 earnings season takes off

Rotation i gang, men forsætter det?

Risiko appetit var ikke gemt langt væk

HCA SaaS update May 2024: Status for the year – and are you ready for our annual SaaS seminar?

Q1 2024 reports ahead and focus on our SaaS sector report

Investorer havde svært ved at finde retning

After six months of outperformance, it seems investors are still only discounting low to average potential in BioTech and Life Science stocks

Share price rebounds in the Danish SaaS sector

Så længe rentesænkninger ikke kan afvises helt – uundgåeligt rally i risikoaktiver

Biotech and Life Science indexes finally moving out of the shadow, but unfortunately, not all investors nor companies are affected